Research ArticleCancer

Signaling from mTOR to eIF2α mediates cell migration in response to the chemotherapeutic doxorubicin

See allHide authors and affiliations

Science Signaling  17 Dec 2019:
Vol. 12, Issue 612, eaaw6763
DOI: 10.1126/scisignal.aaw6763
PDF Container

Stay Connected to Science Signaling

Navigate This Article